At this time, there have been several previously published and formally analyzed systematic reviews and meta-analysis of published studies on the GSTP1, GSTM1 and GSTT1 variants and the risk of primary brain tumors, including glioma 1, 2, 38-40. This evidence concerns the gene GSTM1 and central nervous system cancer.